Feng, Lijun
Lu, Wei
Liu, Jiayi
Chen, Zining
Jin, Junyan
Qian, Ningjing
Pan, Jingnan
Wang, Lijuan
Xiang, Jianping
Jiang, Jun
Wang, Yaping
Funding for this research was provided by:
the General scientific research project of the Zhejiang Education Department (Y202249433)
Key Research and Development Program of Zhejiang Province (2024C03095)
National Natural Science Foundation of China (82170332)
Medicine and Health Science and Technology Project of Zhejiang Province (2022KY805)
the State Key Laboratory of Transvascular Implantation Devices (SKLTID2024001)
Article History
Received: 31 March 2025
Accepted: 25 August 2025
First Online: 26 September 2025
Declarations
:
: The study was approved by the Human Research Ethics Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (No2023-1150, Date 2024/01/24) and conducted in accordance with the principles outlined in the Helsinki Declaration. In addition, all participants approved and wrote the informed consent.
: Not applicable.
: Dr. Jianping Xiang is the principal scientist of ArteryFlow Technology. All other authors have reported that they have no relationships relevant to the contents.